Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 424

1.

CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.

de Masson A, Bouaziz JD, Le Buanec H, Robin M, O'Meara A, Parquet N, Rybojad M, Hau E, Monfort JB, Branchtein M, Michonneau D, Dessirier V, Sicre de Fontbrune F, Bergeron A, Itzykson R, Dhédin N, Bengoufa D, Peffault de Latour R, Xhaard A, Bagot M, Bensussan A, Socié G.

Blood. 2015 Jan 20. pii: blood-2014-09-599159. [Epub ahead of print]

PMID:
25605369
[PubMed - as supplied by publisher]
2.

A refined risk score for acute GVHD that predicts response to initial therapy, survival and transplant-related mortality.

MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JL, Jones R, Arora M, Blazar BR, Holtan SG, Jacobsohn D, Pasquini M, Socie G, Antin JH, Levine JE, Weisdorf DJ.

Biol Blood Marrow Transplant. 2015 Jan 10. pii: S1083-8791(15)00003-8. doi: 10.1016/j.bbmt.2015.01.001. [Epub ahead of print]

PMID:
25585275
[PubMed - as supplied by publisher]
3.

Impact of the revised International Prognostic Scoring System cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.

Koenecke C, Göhring G, de Wreede LC, van Biezen A, Scheid C, Volin L, Maertens J, Finke J, Schaap N, Robin M, Passweg J, Cornelissen J, Beelen D, Heuser M, de Witte T, Kröger N.

Haematologica. 2014 Dec 31. pii: haematol.2014.116715. [Epub ahead of print]

PMID:
25552702
[PubMed - as supplied by publisher]
Free Article
4.

Comparison of Unrelated Cord Blood and Peripheral Blood Stem Cell Transplantation in Adults with Myelodysplastic Syndrome after Reduced-Intensity Conditioning Regimen: A Collaborative Study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.

Robin M, Ruggeri A, Labopin M, Niederwieser D, Tabrizi R, Sanz G, Bourhis JH, van Biezen A, Koenecke C, Blaise D, Tischer J, Craddock C, Maillard N, Mohty M, Russel N, Schetelig J, Finke J, Gluckman E, de Witte TM, Rocha V, Kroger N.

Biol Blood Marrow Transplant. 2014 Dec 19. pii: S1083-8791(14)01384-6. doi: 10.1016/j.bbmt.2014.11.675. [Epub ahead of print]

PMID:
25529382
[PubMed - as supplied by publisher]
5.

High Number of Memory T Cells is Associated with Higher Risk of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.

Loschi M, Porcher R, Peffault de Latour R, Vanneaux V, Robin M, Xhaard A, de Fontebrune FS, Larghero J, Socie G.

Biol Blood Marrow Transplant. 2014 Dec 17. pii: S1083-8791(14)01409-8. doi: 10.1016/j.bbmt.2014.12.009. [Epub ahead of print]

PMID:
25528387
[PubMed - as supplied by publisher]
6.

Should Patients With High-Risk or Transformed Myelodysplastic Syndrome Proceed Directly to Allogeneic Transplant Without Prior Cytoreduction by Remission-Induction Chemotherapy or Hypomethylating Agent Therapy?

de Witte TM, Bowen D, Robin M, Malcovati L, Mufti G, Niederwieser D, Yakoubagha I, Kröger N; Myelodysplastic Syndrome Stem Cell Transplant Guidelines Preparation Group from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation and the European LeukemiaNet.

Clin Lymphoma Myeloma Leuk. 2014 Sep;14S:S42-S45. doi: 10.1016/j.clml.2014.06.015. Review.

PMID:
25486954
[PubMed - as supplied by publisher]
7.

Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

Peffault de Latour R, Fremeaux-Bacchi V, Porcher R, Xhaard A, Rosain J, Cadena Castaneda D, Vieira-Martins P, Roncelin S, Rodriguez-Otero P, Plessier A, Sicre de Fontbrune F, Abbes S, Robin M, Socié G.

Blood. 2014 Dec 4. pii: blood-2014-03-560540. [Epub ahead of print]

PMID:
25477495
[PubMed - as supplied by publisher]
8.

Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.

Warlick ED, Peffault de Latour R, Shanley R, Robin M, Bejanyan N, Xhaard A, Brunstein C, Sicre de Fontbrune F, Ustun C, Weisdorf DJ, Socie G.

Biol Blood Marrow Transplant. 2015 Feb;21(2):357-63. doi: 10.1016/j.bbmt.2014.10.030. Epub 2014 Nov 6.

PMID:
25452032
[PubMed - in process]
9.

Human metapneumovirus pneumonia in patients with hematological malignancies.

Godet C, Le Goff J, Beby-Defaux A, Robin M, Raffoux E, Arnulf B, Roblot F, Frat JP, Maillard N, Tazi A, Bergeron A.

J Clin Virol. 2014 Dec;61(4):593-6. doi: 10.1016/j.jcv.2014.08.019. Epub 2014 Sep 1.

PMID:
25440914
[PubMed - in process]
10.

Cyclosporin and methotrexate-related pharmacogenomics predictors of acute graft-vs-host disease.

Laverdière I, Guillemette C, Tamouza R, Loiseau P, Peffault de Latour R, Robin M, Couture F, Filion A, Lalancette M, Tourancheau A, Charron D, Socié G, Lévesque E.

Haematologica. 2014 Nov 25. pii: haematol.2014.109884. [Epub ahead of print]

PMID:
25425682
[PubMed - as supplied by publisher]
Free Article
11.

Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.

Itzykson R, Robin M, Moins-Teisserenc H, Delord M, Busson M, Xhaard A, de Fontebrune FS, Peffault de Latour R, Toubert A, Socié G.

Haematologica. 2015 Jan;100(1):114-23. doi: 10.3324/haematol.2014.113415. Epub 2014 Sep 26.

PMID:
25261095
[PubMed - in process]
Free PMC Article
12.

Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML.

Sébert M, Porcher R, Robin M, Adès L, Boissel N, Raffoux E, Xhaard A, Dhedin N, Larghero J, Himberlin C, Delmer A, Fenaux P, Dombret H, Socié G, de Latour RP.

Bone Marrow Transplant. 2015 Jan;50(1):74-81. doi: 10.1038/bmt.2014.199. Epub 2014 Sep 22.

PMID:
25243624
[PubMed - in process]
13.

Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication.

Glauzy S, Soret J, Fournier I, Douay C, Moins-Teisserenc H, Peffault de Latour R, Maki G, Robin M, Socié G, Toubert A, Clave E.

Blood. 2014 Oct 9;124(15):2459-62. doi: 10.1182/blood-2014-05-573303. Epub 2014 Sep 2.

PMID:
25185266
[PubMed - in process]
14.

Modulation of metabolizing enzymes by bisphenol a in human and animal models.

Quesnot N, Bucher S, Fromenty B, Robin MA.

Chem Res Toxicol. 2014 Sep 15;27(9):1463-73. doi: 10.1021/tx500087p. Epub 2014 Aug 29.

PMID:
25142872
[PubMed - in process]
15.

Dual effect of thiol addition on fluorescent polymeric micelles: ON-to-OFF emissive switch and morphology transition.

Mabire AB, Robin MP, Willcock H, Pitto-Barry A, Kirby N, O'Reilly RK.

Chem Commun (Camb). 2014 Oct 9;50(78):11492-5. doi: 10.1039/c4cc04713c.

PMID:
25130319
[PubMed - in process]
16.

Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.

Kheav VD, Busson M, Scieux C, Peffault de Latour R, Maki G, Haas P, Mazeron MC, Carmagnat M, Masson E, Xhaard A, Robin M, Ribaud P, Dulphy N, Loiseau P, Charron D, Socié G, Toubert A, Moins-Teisserenc H.

Haematologica. 2014 Dec;99(12):1860-7. doi: 10.3324/haematol.2014.108407. Epub 2014 Aug 1.

PMID:
25085354
[PubMed - in process]
Free PMC Article
17.

Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT.

Chalandon Y, Passweg JR, Guglielmi C, Iacobelli S, Apperley J, Schaap NP, Finke J, Robin M, Fedele R, Bron D, Yakoub-Agha I, van Biezen A, de Witte T, Kröger N, Olavarria E; Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Haematologica. 2014 Sep;99(9):1492-8. doi: 10.3324/haematol.2013.100198. Epub 2014 Jul 4.

PMID:
24997146
[PubMed - in process]
Free Article
18.

Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis.

Robin M, Giannotti F, Deconinck E, Mohty M, Michallet M, Sanz G, Chevallier P, Cahn JY, Legrand F, Rovira M, Passweg J, Sierra J, Nguyen S, Maillard N, Yakoub-Agha I, Linkesch W, Cannell P, Marcatti M, Bay JO, Chalandon Y, Kröger N, Gluckman E, Rocha V, Olavarria E, Ruggeri A; Eurocord and Chronic Malignancies Working Party-European Group for Blood and Marrow Transplantation (CMWP-EBMT).

Biol Blood Marrow Transplant. 2014 Nov;20(11):1841-6. doi: 10.1016/j.bbmt.2014.06.011. Epub 2014 Jun 16.

PMID:
24946719
[PubMed - in process]
19.

Late donor bone marrow failure after allogeneic hematopoietic stem cell transplantation.

Meunier M, Manez AC, Xhaard A, Peffault de Latour R, de Fontbrune FS, Dhedin N, Socié G, Robin M.

Transplantation. 2014 Jun 27;97(12):e75-7. doi: 10.1097/TP.0000000000000177. No abstract available.

PMID:
24933256
[PubMed - indexed for MEDLINE]
20.

Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.

Hussein AA, Halkes CM, Socié G, Tichelli A, von dem Borne PA, Schaap MN, Foa R, Ganser A, Dufour C, Bacigalupo A, Locasciulli A, Aljurf M, Peters C, Robin M, van Biezen AA, Volin L, De Witte T, Marsh J, Passweg JR, Kröger N; Severe Aplastic Anemia and Chronic Malignancies Working Parties of the European Group for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1448-50. doi: 10.1016/j.bbmt.2014.05.028. Epub 2014 Jun 6.

PMID:
24910382
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk